Denali Therapeutics Inc.
DNLI
$24.20
-$0.72-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 710.47M | 987.68M | 867.88M | 848.20M | 898.95M |
| Total Receivables | 5.43M | 1.60M | 2.18M | 1.90M | 1.40M |
| Inventory | 4.14M | -- | -- | -- | -- |
| Prepaid Expenses | 33.89M | 33.47M | 30.60M | 32.49M | 34.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 753.93M | 1.02B | 900.66M | 882.60M | 934.71M |
|
|
|||||
| Total Current Assets | 753.93M | 1.02B | 900.66M | 882.60M | 934.71M |
| Net Property, Plant & Equipment | 113.42M | 117.27M | 119.94M | 123.21M | 130.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 35.25M | 36.00M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.83M | 11.22M | 10.94M | 10.11M | 22.97M |
| Total Assets | 1.16B | 1.27B | 1.14B | 1.06B | 1.17B |
|
|
|||||
| Total Accounts Payable | 11.81M | 40.38M | 3.33M | 6.75M | 10.84M |
| Total Accrued Expenses | 48.12M | 44.80M | 64.37M | 51.58M | 50.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.18M | 9.86M | 9.55M | 9.24M | 10.29M |
| Total Finance Division Other Current Liabilities | 19.98M | 15.12M | 21.10M | 22.58M | 19.86M |
| Total Other Current Liabilities | 19.98M | 15.12M | 21.10M | 22.58M | 19.86M |
| Total Current Liabilities | 90.08M | 110.16M | 98.35M | 90.15M | 91.06M |
|
|
|||||
| Total Current Liabilities | 90.08M | 110.16M | 98.35M | 90.15M | 91.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.51M | 30.19M | 32.74M | 35.24M | 37.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 205.19M | 199.58M | -- | 4.04M | 10.44M |
| Total Liabilities | 322.78M | 339.93M | 131.09M | 129.42M | 139.19M |
|
|
|||||
| Common Stock & APIC | 3.14B | 3.11B | 3.06B | 2.85B | 2.82B |
| Retained Earnings | -2.31B | -2.18B | -2.05B | -1.92B | -1.80B |
| Treasury Stock & Other | -1.97M | -682.00K | 682.00K | 1.10M | 939.00K |
| Total Common Equity | 835.18M | 926.10M | 1.01B | 926.20M | 1.03B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 835.18M | 926.10M | 1.01B | 926.20M | 1.03B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 835.18M | 926.10M | 1.01B | 926.20M | 1.03B |
|
|
|||||